Description
This assay uses the Luminex® 200™ platform.
Attention Clinicians! Our Long COVID Vascular Health 18-Plex Panel is now available for clinical diagnostics under CLIA regulation as a Laboratory Developed Test (LDT). This panel includes two simultaneous assays (HDAGP17 and HDSAA6) to assess vascular and endothelial integrity, coagulation, and inflammation—key aspects of long COVID. Running both assays together ensures efficient, high-quality results with a rapid turnaround. For details and to enhance your diagnostic capabilities, visit our patient diagnostics webpage. Reference intervals are available for PLASMA-EDTA samples.
Consider this assay for targeted analysis of cardiovascular disease markers. The Human Cardiovascular Disease Panel 2 6-Plex Discovery Assay® Array measures six biomarkers simultaneously related to cardiovascular inflammation and coagulation: ADAMTS13, SAA, sP-Selectin, sICAM-1, sVCAM-1 and D-Dimer.
Ideal for research on cardiovascular diseases such as myocardial infarction and stroke, this assay provides insights into markers like sP-Selectin and D-Dimer. For example, sP-Selectin is associated with endothelial activation, while D-Dimer is a marker of clot formation and breakdown.
Discover the power of precision with our The Human Cardiovascular Disease Panel 2 6-Plex Discovery Assay® Array, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency. Streamline your research and unlock a new level of detail with our advanced multiplex assay solution.
Click here for information on shipping biological samples for Discovery Assays